Get all your news in one place.
100's of premium titles.
One app.
Start reading
Top News
Top News
Politics

FDA Approves Novo Nordisk's Wegovy For Lowering Heart Risks

Boxes of Wegovy lie beside a packaging line at Novo Nordisk's facility in Hillerod

The US Food and Drug Administration (FDA) has granted approval to Novo Nordisk's Wegovy for its effectiveness in reducing heart risks. Wegovy, a medication designed to aid in weight management, has shown promising results in clinical trials.

Individuals who are overweight or obese often face an increased risk of developing heart disease. By addressing weight management, Wegovy aims to help lower this risk and improve overall cardiovascular health.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.